A page in the reference notebook
Retatrutide
Also listed as: LY3437943
Keep the record, its references, and your reading question together.
- Product status
- Investigational
- Evidence label
- Randomized evidence
- Body topics
- Metabolism
Status as of
Reference fields
Read the fields together.
- Mechanism
- Activates GIP, GLP-1 and glucagon receptors.
- Evidence
- A randomized obesity trial was funded by Lilly.
- Limitations
- Trial averages do not predict an individual outcome.
- Safety
- The trial reported gastrointestinal adverse events.
- Route and product context
- Studied as a subcutaneous injection.
- Approval scope
- Investigational; no FDA-approved product.
A little room to think
One clearer reading question.
Read a headline and its supporting statement as separate claims. A small change in wording can add a large promise. If a statement about a possibility becomes a prediction, the headline now needs support for that prediction. If a narrow description becomes a general assurance, its scope has expanded. Trace the added promise by naming the words that introduced it. Then ask whether the supporting material addresses that stronger claim. This approach keeps the useful part of a message while making it harder for an attractive headline to borrow certainty it has not established.
Questions to keep nearby
- Which words make the headline stronger than the statement used to support it?
- Does the supporting material address the added prediction or only the narrower description?
- How could the headline be phrased without adding an unsupported promise?
Follow the record
Source list
- FDA GLP-1
FDA · Checked
- Jastreboff
PubMed · Checked